Diabetes Therapies

Insulin Gene Transfer Might Provide Alternative To Injections Or Pump

Published in Gene Therapy Weekly, November 15th, 2001

by Sonia Nichols, senior medical writer - Gene therapy might replace insulin injections and pumps as the preferred method for treating type 1 diabetes some day.

Patients with type 1 diabetes do not produce sufficient levels of insulin in pancreatic beta cells. Currently, several studies are looking at ways to stimulate insulin production by manipulating cell activity. A team at the University of Pennsylvania School of Medicine has designed a way to transfer the genes for human insulin into special cells of the pancreas called acinar cells. According to the researchers, they have obtained positive results using this new form of gene therapy in diabetic mice.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2001-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry